Boulder Hill Capital Management’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
OAM
Boulder Hill Capital Management's ASTH Position: Q1 2022 in Review
Boulder Hill Capital Management sold out of Astrana Health (ASTH) in Q1 2022, closing a stake of 9,100 shares — an estimated $669K sold.
Boulder Hill Capital Management first reported a position in ASTH in Q4 2021 and held it in 1 quarter. The position peaked at $669K in Q4 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.
- Boulder Hill Capital Management reported no remaining Astrana Health position as of Q1 2022 after selling out during the quarter.
- Boulder Hill Capital Management sold 9,100 Astrana Health shares in Q1 2022, an estimated $669K.
- Boulder Hill Capital Management first reported a position in Astrana Health in Q4 2021 and held it in 1 quarter.
- Boulder Hill Capital Management's Astrana Health position peaked at $669K in Q4 2021.
- 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.
Based on Boulder Hill Capital Management's 13F filing for Q1 2022, filed 12 May 2022.